INSMED Inc (INSM) stock
INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30100% above fair value
$121.16+3.09 (+2.62%)
Close on Nov 13, 2026Market cap $26.58BP/E –Yield –
Insmed ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2023 it was -$704.13M. The highest annual figure on record is -$7.97M in fiscal 2009.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$704.13M | – |
| FY2022 | Dec 31, 2022 | -$452.02M | – |
| FY2021 | Dec 31, 2021 | -$365.99M | – |
| FY2020 | Dec 31, 2020 | -$256.13M | – |
| FY2019 | Dec 31, 2019 | -$230.05M | – |
| FY2018 | Dec 31, 2018 | -$303.74M | – |
| FY2017 | Dec 31, 2017 | -$186.02M | – |
| FY2016 | Dec 31, 2016 | -$171.00M | – |
| FY2015 | Dec 31, 2015 | -$115.51M | – |
| FY2014 | Dec 31, 2014 | -$86.29M | – |
| FY2013 | Dec 31, 2013 | -$54.34M | – |
| FY2012 | Dec 31, 2012 | -$41.88M | – |
| FY2011 | Dec 31, 2011 | -$61.38M | – |
| FY2010 | Dec 31, 2010 | -$8.04M | – |
| FY2009 | Dec 31, 2009 | -$7.97M | – |
See a number that looks wrong?